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2212-0661/© 2014 The Author. Published by Elsevier B.Va b s t r a c ta r t i c l e i n f oThe sharing of patient data, such as test results, is important for appropriately treating patients. Inclusion of this
data allows for clinical error prevention, particularly if a new clinician becomes involved. If genetic information,
including family history or genetic test results, is not accessible to treating physicians, caremay suffer. Innovation
is needed to address the problem of lack of access to important data, such as genomic test results, not structured
to ﬁt into an EHR.
Without data integration care will, and does suffer. Innovations, albeit long in the making (Blatt, 2013), are
improving the care of patients. The next step forward is better utilization of available information, including
genomic test results.
© 2014 The Author. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction 2. The need to innovateElectronic health records (EHR) are a commonly used vehicle to
share patient information.
In the absence of an EHR, a patient with increased risk for heart
disease in her 20s, as determined by family history and a genetic test re-
sult that is not documented in the EHR, may not be given appropriate
care by her primary care physician (PCP) if he/she is lacking access to
the genomic test results. Integrating genomic results into the EHR is
clearly necessary to incorporating the beneﬁts of genomic knowledge
to provide better care, enable prevention, provide better/more targeted
care, and ultimately improve outcomes.
Some challenges to integrating genomic data into the EHR
(Williams, 2012):
• Inadequate education of clinical workforce as it relates to genomic
information.
• Insufﬁcient evidence to demonstrate beneﬁt from this integration.
• Concerns about privacy, and security of the data.
• Concerns about provider payment.
Medical schools do not teach doctors how to interpret genetic/
genomic information. Instead physicians receive narrative reports con-
taining result interpretations, often with indications for clinical action,
which importantly are not structured for integration in the patient's
EHR Scanning in a report does not enable other physicians easy access
to potentially important information for care decisions. The lack of
easy access to genetic/genomic information is, and will increasingly
be, an important care issue.. This is an open access article underInnovation is typically met with fear and skepticism, especially in an
industry such as healthcare.
Disruptive innovation is required to create the kind of shake up
needed for resistance to fade and change to take hold. A revolutionary
process that allows for seamless integration of genomic results and fam-
ily history, into an EHR and for that information to be used by clinicians
to inform their decision making processes.3. What types of innovation can help?
Innovation is the onlyway to solve the challenges related to integra-
tion of genomic data into the EHR.
Innovations that enable storing and sharing test results in EHRs are
necessary to ensuring that genomic medicinewill have the desired out-
comes. It is important that innovative solutions take into account the
needs of patients, clinicians, and others who may be involved in the
care process (such as insurance companies). One possible solution
could be a physician alert when an increased risk of an adverse condi-
tion, such as the increased risk of heart disease mentioned in the begin-
ning of the commentary, is identiﬁed through genomic test result and
family history. In order to be of use for clinical decision-making,
genomic information must be clear, complete, relevant, timely, and ac-
tionable. Vendors would also need to be involved in this process. They
need to create products that allow for the improved storage and
management of data, instead of side by side, or narrative reporting,
they could create an EHR that allowed for a more expansive report/
interpretation if needed, but could allow the clinician and patient tothe CC BY license (http://creativecommons.org/licenses/by/3.0/).
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genetic testing and the patient's overall healthcare needs.
Innovations that train and connect medical students with genomic
information and interpretation of that information could be valuable
for ensuring that newly minted physicians are knowledgeable about
the types of information obtained by different types of tests. Given
that studies will continue to update information available and interpre-
tations of data (such as test results), this is a good skill for genomic
medicine physicians to have.
A great example of how genomic data can be used to accomplish
these goals within an EHR is currently underway at Vanderbilt
University Medical Center (DeGaspari, 2014). Vanderbilt has developed
a pharmacogenomic resource for enhanced decision in care and treat-
ment (PREDICT) project (DeGaspari, 2014). PREDICT was implemented
in 2010 as part of Vanderbilt's quality improvement initiative and since
then has genotyped more than 14,000 patients (DeGaspari, 2014). This
project uses advanced EHR and clinical decision support (CDS) tools, to
assist clinicians with genome-informed decision making (DeGaspari,
2014).
This program has allowed 370 clinicians to ﬁnd patients that are at
risk for side effects or other undesirable outcomes from seven types of
drugs, with sufﬁcient data on prescribing and genetic risk factors
identiﬁed (DeGaspari, 2014). These clinicians found that 88.3% of
patients tested had some form of genetic risk related to these drugs
(DeGaspari, 2014). These are patients that can now have a better stan-
dard of care, because their clinicians are away of the risk related to
their body's processing of a particular drug commonly used to treat
their condition. Clinicians at Vanderbilt, when they ﬁnd a risk, have pro-
cesses in place for selecting an alternative drug therapy (DeGaspari,
2014). This is an example of how innovations related to genomic data
can assist patients and clinicians in improving patient outcomes, and
also in cutting costs of care through the avoidance of unnecessary
(and possibly harmful) usage of drugs (DeGaspari, 2014).
PREDICT could serve as a template for other innovations, because it
only uses drugs that have enough information for genomic risk to beseen, and it is allowing clinicians across a network to improve the out-
comes of patients, while avoiding costs related to adverse reactions.
This type of innovation could be beneﬁcial to the healthcare system as
a whole, but especially to the rural and critical access patients, who
may need to drive for miles to pick up prescriptions and see doctors
for care related to adverse events.
4. Conclusion
The demand for genomic medicine is not going to go away, genomic
data is here and it is here to stay (Blatt, 2013). Innovative solutions to
enable genomic data to reside in EHRs are urgently needed, less we cre-
ate a bottleneck of millions of terabytes of clinically relevant data that
has no way of entering the EHR. It is important that the industry inno-
vates to provide better service to patients, and give clinicians the tools
they need for using all clinically relevant information (such as test
results).
The road to innovation in healthcare has many challenges, some of
which were outlined in this commentary. The alternative to innovation
is to be left behind in a graveyard of obsolescence. The consequences for
patients are farworse, for patients the burden of not creating innovative
solutions is poor quality patient care, which in some cases will result
in death due to some genetic/genomic data that is not presented in an
actionable manner in the EHR.
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